As the novel coronavirus, COVID-19, continues to spread across the globe, concerns are deepening with it—and rightfully so. Even experts don’t yet fully understand how the virus works.

As artificial intelligence (AI) is increasingly brought to bear in diagnosis, therapeutic intervention, and personalized medicine, some experts are expressing concern over its reliability and accuracy.

Is social media, a ubiquitous platform in the digital age, the root of a modern paradox: causing widespread feelings of isolation even as it brings us (virtually) together? Gillian Galen, PsyD, a clinical psychologist at McLean Hospital, says there’s overwhelming evidence that it is.

Is all artificial intelligence (AI) created equal? A recent groundbreaking Partners HealthCare initiative with GE Healthcare points to no.

For many early-career investigators, the only limit to their high-potential research is the funding needed to support it. Imagine, then, what an unrestricted gift of $100,000 per year for three years could mean—to their laboratories, to medicine, and, potentially, to patient care.

A new, genetic-level discovery at Brigham and Women’s Hospital offers a potential pathway toward better treatments for psoriasis, an often-debilitating condition impacting at least 100 million individuals worldwide.